Thermo Fisher Scientific Inc. provided earnings guidance for the first quarter and full year of 2020. From an organic growth standpoint, The company expects first quarter to be a couple of points lower than the full year due to the days impact and the prior year comps, particularly in the Analytical Instruments segment. In terms of revenue guidance, the company expects to deliver between $26.61 billion and $27.01 billion in 2020, which would result in reported revenue growth of 4% to 6%.